Metraipolis › archive › dc_0cc4fa7075e7
BAFF/APRIL expression-guided telitacicept therapy demonstrates superior efficacy in systemic lupus erythematosus patients: a real-world comparative study — Europe PMC PMID:40917862
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40917862
- DOI
- 10.3389/fmed.2025.1608085
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T10:49:42.187Z
- SHA-256 of the archived text
8451ae571f6713e5ee36ef6206187c0cd1e7053ea09059508fed28f298334247- Stable URL of this page
https://metraipolis.com/documento/dc_0cc4fa7075e7
How to cite
BAFF/APRIL expression-guided telitacicept therapy demonstrates superior efficacy in systemic lupus erythematosus patients: a real-world comparative study — Europe PMC PMID:40917862 — Europe PMC (en), https://europepmc.org/article/MED/40917862 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0cc4fa7075e7 (Metraipolis archive dc_0cc4fa7075e7, sha256 8451ae571f6713e5ee36ef6206187c0cd1e7053ea09059508fed28f298334247)
BibTeX
@misc{dc0cc4fa7075e7,
title = {BAFF/APRIL expression-guided telitacicept therapy demonstrates superior efficacy in systemic lupus erythematosus patients: a real-world comparative study — Europe PMC PMID:40917862},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40917862},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0cc4fa7075e7; sha256 8451ae571f6713e5ee36ef6206187c0cd1e7053ea09059508fed28f298334247},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40917862. Agents can read the archived copy with the MCP tool read_document.